Investors! Grow with us

Our solution

Particularly the pioneering Generation Module, is the first of its kind on the market, offering unparalleled capabilities in the automation of clinical trial documentation.

The Generation Module stands out as a transformative tool, specifically designed to generate essential documentation for clinical studies. From creating detailed plans and supporting documentation to presetting electronic messages, generating monitoring reports, and assisting in final study reports, this module is a comprehensive solution that streamlines and enhances the entire documentation process.

Developed using best practices and backed by the expertise of a pharmaceutical company with a remarkable 94+% success rate in clinical trials, the Generation Module has been meticulously crafted since 2015 and has undergone rigorous testing in real-world scenarios since 2017.Particularly the pioneering Generation Module, is the first of its kind on the market, offering unparalleled capabilities in the automation of clinical trial documentation.

The market demand for such a solution is immense, and with our prototype already in successful use, we are uniquely positioned to scale rapidly. This is where you come in. By investing in Vilintra, you are not just investing in a product, but in a proven innovation that addresses a critical need in the pharmaceutical industry.

our support will enable us to expand our reach, grow our capabilities, and solidify our position as the leader in clinical trial management solutions.Particularly the pioneering Generation Module, is the first of its kind on the market, offering unparalleled capabilities in the automation of clinical trial documentation.

Join us in this exciting journey to shape the future of healthcare and achieve remarkable returns. Invest in Vilintra today and be part of a revolution that will set new standards in clinical trial efficiency and accuracy